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Introduction 
 
 The role of metals in the development of human culture and technology became 
significant around 4000 B.C., when people discovered how they can extract copper 
from its ores and manufacture objects of everyday use, and the copper era began. With 
changing way of life, humans started to use other easily extractable metals from the 
environment, such as tin or lead. As time went by, metals became vital for everyday life 
but they also presented a source of environmental pollution and harmful human 
exposure. 
 Several terms are used for the classification of metals, such as light or heavy 
metals, essential, beneficial, toxic and trace metals. It has been customary to group 
metals into light and heavy ones based on their density, but over the years, no 
consistency was achieved in this density-based definition. Recently it was suggested 
that heavy metals should be rather defined based on their position in the periodic table, 
because this position refers to the chemical properties and hence the possible toxic 
effect. According to this classification, transition elements, such as chromium (Cr), 
manganese (Mn) and iron (Fe), as well as rare earth metals, post-transition metals and 
metalloids should be considered as heavy metals. 
 Heavy metals as elements do persist in the environment. A lot of metals are 
xenobiotics, substances which can be neither utilized nor neutralized by the organism. 
This is so because they used to have minimal presence (and, hence, bioavailability) 
during the evolution of life, before anthropogenic emission into the environment had 
begun; and because they are either completely useless or toxic for the human organism 
(e.g. Hg, Pb or Cd) or essential as micronutrients but toxic when overdosed (Mn, Cr, 
Cu, etc.). 
 Emission of heavy metals into the environment can be of natural or 
anthropogenic origin. The most important man-made sources are ore processing and 
combustion processes (power generation or waste incineration) raising the concern of 
occupational health hazard. Due to the environmental transport of metals through air, 
water and the food chain, distant areas can be polluted leading to exposure of the 
general population. 
 The concentration of essential elements in human and animal organism is under 
homeostatic control, and the uptake from the environment (via food and/or drinking 
water) is regulated by the nutritional demand. Disturbances in the regulatory 
mechanisms can result in either insufficient (deficiency) or excess (toxicity) metal 
uptake. 
 Ingested heavy metals are absorbed from the intestine to around 10%. Common 
metal transport mechanisms, responsible for the uptake of essential metals, are involved 
in that, which explains why individuals with Fe or Ca deficiency absorb more of the 
toxic metals (e.g. excess Mn absorption in anaemic individuals, or lead absorption in 
children requiring more Ca for bone growth). Trivalent ions of toxic metals like Mn or 
Cr use transferrin (Tf) for transport from the blood, to pass the blood-brain barrier 
(BBB) and to reach the central nervous system (CNS). 
 Inhalational exposure occurs predominantly in the occupational environment. 
Miners and metal workers are exposed to airborne metal particles first of all, but 
inhabitants around industrial sites are also at risk. Metal-containing dusts and fumes are 
generated in the whole life cycle of metals, from ore mining through smelting and final 
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product manufacturing to waste management and recycling, and are found in the 
workplace atmosphere sometimes at hazardous concentrations.  
 One of the most common sources of such metal aerosols is welding. Welding 
fume is a complex mixture of metal oxides and materials of the electrode. The most 
common elements in steel that welders are primarily exposed to by inhalation are Fe, 
Mn and Cr. Airborne particles, released into the environment by welding, have major 
adverse health effects, causing among others neurological disorders and respiratory 
illnesses. Welders who are at excessive exposure may be at risk of developing early 
Parkinson’s disease or manganism caused by overexposure to Mn. The neurotoxicity of 
Mn has been described extensively but the role that other agents (such as Cr or Fe) 
peculiar to welding may play in the causation of the above mentioned neurological 
disorders are still unknown.  
 The extent of metal exposure is influenced by numerous factors including 
chemical form in which the metal is present in the particles and the particle size. Much 
of the particles derived from the welding process have a diameter below 100 nm, i.e. 
they are nanoparticles (NPs). The potential health impact is influenced by the site of 
deposition (for NPs, mostly nasopharyngeal and alveolar). Also, the surface-to-mass 
ratio of these particles is extremely high, which means a small mass fraction within a 
complete aerosol sample, but with a high number of particles and a very high and 
reactive overall surface. The composition of NPs is determined by the composition of 
the materials worked with or burnt. Inhaled NPs have various interactions in a living 
system and can contribute to adverse health effects in the respiratory tract as well as in 
extrapulmonary organs. Extrapulmonary effects of NPs depend on several factors 
including particle solubility, particle or aggregate size, the site of deposition, and the 
integrity of the alveolar epithelial lining. Inhaled NPs deposited in the nasopharynx can 
pass a healthy blood-brain barrier (BBB) and reach the CNS via direct transport along 
the olfactory pathway. Particles that reach the alveoli are translocated directly to the 
blood and transported further. Pulmonary circulation continues to supply the brain with 
significant amounts of welding-related metals long after the exposure has been 
terminated. Also for the general population, inhalation may be a significant source of 
NP exposure, e.g. from car exhaust because most of the metals leaving the engine with 
the exhaust gases are in form of microscopic and submicroscopic oxide particles. 
Extensive use of NPs means that, besides inhalation, routes of dermal and oral uptake 
should be also considered. 
 Mn is an essential micronutrient, a component of several metalloenzymes, but 
toxic when overdosed. One of the most important applications of Mn is steelmaking, 
and the coating of welding rods. In the production of dry cells, MnO2 is used. Maneb 
and Mancozeb represent the use of Mn in agricultural fungicides; while the contrast 
agent trisodium mangafodipir (Mn-DPDP, Teslascan) is used in magnetic resonance 
imaging for diagnostic purposes. Most of the inhalable Mn found in (both workplace 
and residential) environment is of anthropogenic origin. The typical form of 
occupational Mn exposure is chronic inhalation (usually but not exclusively as MnO2), 
which may result in severe neurological disorders; starting with apathy, asthenia and 
headache, and ending in Parkinson-like syndrome. Inhalational Mn exposure for the 
general public may result from the Mn-containing petrol additive, but ingestion may be 
equally important for them. Abnormally high Mn levels in the drinking water were 
reported in Japan, in Greece and in the USA, causing CNS symptoms in the residents of 
the polluted areas, but cases of Mn overexposure among patients receiving Mn-
supplemented parenteral nutrition were also reported. Disorders with 
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electrophysiological signs after Mn exposure include myoclonus in welders and 
epileptic activity in over-exposed children. EEG and visual evoked potential alterations 
were observed in persons with elevated blood Mn. 
 Fe is of great value in biology: it is essential for both plant and animal life, e.g. 
by carrying oxygen and thus enabling vital functions, but due to its advantageous 
technical properties, Fe is also of high importance in numerous alloys, first of all in 
steels. In case of overload, Fe can deposit in certain mitochondria rich organs, and 
causes disruption of the mitochondrial energy production by decreasing enzyme 
activity, and leads to generation of ROS responsible for the toxic effect. In certain 
neurodegenerative diseases, such as Parkinson’s or Alzheimer’s disease, accumulation 
of Fe in the basal ganglia and induction of oxidative stress is held responsible. Another 
possible mechanism of Fe toxicity involves rupture of lysosomes and release of 
digestive enzymes into the cytoplasm, which may end in cell death. After intratracheal 
(it.) instillation of Fe2O3 NPs pulmonary toxicity was studied, but no neurological or 
behavioural tests were conducted. Fe oxide NPs are, on the other hand, of considerable 
interest for biomedical applications, which is yet another reason for examining their 
toxicity.  
 Cr, used in the production of pigments, in leather tanning and in alloy formation, 
is naturally present in the environment and in the living organisms as well. The main 
forms of Cr are the trivalent (Cr
3+
) and the hexavalent (Cr
6+
) state. Cr
3+
 is a component 
of the glucose tolerance factor, thus regulating glucose, protein and fat metabolism. ). 
Environmental Cr
6+
 originates almost totally from human activity; it is more toxic than 
Cr
3+
, is a strong oxidant, carcinogen, allergen and acute irritant. The natural sources of 
Cr in the environment are weathering of rocks and leaching from soils, but exposure of 
the general population is negligible compared to occupational exposure. Occupational 
exposure to Cr
6+
 and Cr
3+
 compounds and their respiratory effects have been described 
several times, but information about the neurological effects is scarce, though it causes 
free radical formation, reduces mitochondrial activity, and studies prove that Cr can also 
reach the brain. Cytotoxicity of nanoparticulate Cr2O3 is higher compared to fine 
particles. Cr NPs were found in in vitro experiments to increase intracellular ROS level 
and to cause oxidative stress. 
 
 
Aims 
 
 This thesis is the continuation of a long line of antecedent research at the 
Department on the neurotoxicity of Mn, in dissolved and more recently in 
nanoparticulate form and on interactions of neurotoxic metals. The overall goal, 
modelling human heavy metal exposure – which is often inhalational but can also be 
oral – more adequately, led to more elaborate experimental designs, one involving the 
combination of several industrially relevant metals, and the other involving more than 
one physicochemical form of one metal. Varying the way and site of administration was 
included also. From all that, the aims of the present PhD work were specified as 
follows: 
 To examine the effects on general toxicological, CNS electrophysiological and 
behavioural parameters exerted by nanoparticulate Mn, Fe and Cr in an identical 
experimental setup; 
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 To repeat these experiments with double and triple combinations of the mentioned 
metals, in order to reveal possible interactions and to have a better model of 
welding fumes and similar industrial emissions;  
 To examine the relationship of external and internal doses in dependence of the 
physicochemical form and site of application of Mn, and on co-application of 
the other two metals; 
 To test whether analysis of the second:first ratio, a method used previously to study 
the CNS effect of the mitochondrial toxin 3-nitropropionic acid and the acute 
effect of Mn, is applicable for detection of neuro-functional alterations induced 
by subacute application of Mn and other metals. 
 
 
Materials and Methods 
 
 Young adult male Wistar rats were obtained from the university’s breeding 
centre. The different experiments were started with different initial body weights, see 
Table 1. The animals were housed, with up to four rats in one cage, under GLP-
equivalent conditions (22±1 ºC, 30-60% relative humidity, 12-h light/dark cycle with 
light on at 06:00), and had free access to tap water and standard rodent chow (Bioplan, 
Isaszeg). 
 The rats were exposed to Mn by per os (po.) and it. administration. In po. 
administration, aqueous solution of MnCl2 was applied, while in it. administration the 
rats were instilled either with aqueous solution of MnCl2, or with a suspension of MnO2, 
Fe3O4 or Cr(OH)3 NPs or their combinations (the treatment schemes are given in Table 
1). 
 MnCl2 was of >99% purity, available commercially (Sigma-Aldrich Hungary). 
The MnO2, Fe3O4 or Cr(OH)3 NPs for Experiment III and IV were synthesized at
 
the 
Department of Physical Chemistry and Materials Science, University of Szeged, Faculty 
of Science and Informatics. 
 Experiment I: For po. administration, 2.5 mg/ml MnCl2 was dissolved in tap 
water, and given as drinking fluid to the 12 animals of the treated group for 6 weeks. 
This amount of Mn was, according to literature data, a small, but at the same time 
relevant dose considering possible Mn intoxication of environmental origin. Animals of 
the control group (n=8) consumed clear tap water during the exposure period. Mn 
content of the tap water used was negligible (0.03 µg/ml), therefore it was disregarded 
at the calculation of cumulative dose. In order to prevent Mn precipitation from tap 
water, 0.25 mg/ml citric acid was added. The pH of the drinking fluid, containing 
MnCl2 and citric acid in the above mentioned concentrations, was 6.7. Based on the 
water consumption of the animals, the solution had no unpleasant taste. 
 During the treatment period, body weight and water consumption of the animals 
was measured daily (for the sake of the latter, the animals were housed alone). From the 
data, cumulative Mn dose (per kg body weight) could be calculated. At the end of the 6-
week treatment, after preparation for electrophysiological investigation (see below) two 
recordings of somatosensory (SS) evoked potentials (EPs) per animal were made in 
urethane anaesthesia. 
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 Experiment II: In this experiment the rats had it. instillations of MnCl2 (0.5 
mg/kg b. w., instillation volume: 1 ml/kg b. w.), once a day, five days per week, for 5 
weeks. The applied dose was based on previous experience and on literature data. The 
rat was put in a glass jar with air-tight lid, saturated with ether vapour. The completely 
anesthetized rat was suspended on a board tilted to 60° from horizontal, by hanging its 
upper incisors in a wire loop. Keeping this way the rat in place and its mouth open, the 
trachea was illuminated transdermally by means of a fibre optic light guide brought into 
direct contact with the animal’s neck. The tongue was pulled forward with a pair of non-
traumatic forceps, and a custom-made laryngoscope was used to gain access to the 
glottis. The MnCl2 solution (or distilled water for the vehicle controls) was instilled into 
the trachea by means of a 1 ml syringe and 1.2 mm diameter plastic tubing, inserted 
between the vocal chords. The electrophysiological recording at the end of the 5-week 
treatment was identical to that done in Experiment I. 
 Experiment III: The rats, divided into 10 groups, were intratracheally instilled 
with a suspension of MnO2, Fe3O4 or Cr(OH)3 NPs (2 or 4 mg/kg b. w.; for details see 
Table 1). Treatment was performed once a day, 5 times per week, for 4 weeks. This 
short period was chosen because experience showed that the nanoparticulate form of 
Mn (and other metals) tends to be more toxic than other (dissolved etc.) forms. MnO2 
and Fe3O4 NPs were suspended in PAA, the vehicle also used to treat the FMVC vehicle 
control group. Cr(OH)3 NPs were suspended in normal saline, so the CrVC control 
group was saline treated. An untreated control (Cont) group was also used because of 
the expectable own effects of the treatment procedure. It. treatment was performed as 
described in Experiment II. At the end of the treatment, open field (OF) test and 
electrophysiological recording was conducted (methods are described below).  
 Experiment IV: In this experiment, animals were treated with the double and 
triple combinations of MnO2, Fe3O4 or Cr(OH)3 NPs. The treatment lasted for 4 weeks; 
it. instillation was performed once a day, 5 times per week (it was supposed that during 
4 weeks the effects will develop but animal loss due to excessive toxicity will be 
minimal). Five groups of animals were set up as detailed in Table 1. The vehicle control 
(VC) group was treated with PAA and normal saline with several hours delay. Fe and 
Mn NPs were both suspended in the PAA medium, and could be administered together. 
Administration of NPs in different vehicles (combinations containing Cr: FC, MC and 
FMC) was separated in time by several hours in order to decrease burden put on the 
lungs by the instillation (that is, to avoid the administration of double volume). It. 
treatment was performed as described in Experiment II. At the end of the treatment, OF 
test and electrophysiological recording was conducted (methods are described below). 
 Preparation and electrophysiological measurement was done after anaesthetizing 
the animals with urethane (1000 mg/kg b. w. intraperitoneally; Reanal, Hungary). The 
head of the rats was fixed in a holder frame, the skin was opened by a mid-sagittal cut, 
and the muscles and connective tissues attached to the skull were removed. Wounds 
were sprayed with 10% Lidocaine, then the left temporal bone was cut along its inner 
circumference by a dental drill bit attached to a mini drill, the bone was lifted, and the 
left hemisphere was thus exposed. The exposed dura surface was covered with a thin 
layer of petroleum jelly in order to protect it from dehydration. The prepared animals 
were wrapped in a warm cloth to maintain body temperature and were put aside for at 
least 30 min for recovery.  
 After the recovery period, the rat was placed into the stereotaxic frame of the 
electrophysiological setup. For recording spontaneous and evoked cortical activity, ball-
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tipped silver recording electrodes were placed on the dura over the primary SS 
projection area of the whiskery pad (barrel field), and over the primary visual (VIS) and 
auditory (AUD) focuses. A stainless steel clamp was attached to the cut skin edge as 
indifferent electrode. 
 Stimulus-evoked activity (sensory EPs) was recorded in each of the experiments. 
SS stimulation was done by electric pulses given through a pair of needles inserted into 
the whiskery skin (3 4 V; 0.05 ms). VIS stimulation was performed by flashes delivered 
by a high-luminescence white LED directly into the contralateral eye of the rat. For 
AUD stimulation, clicks (ca. 40 dB) were applied into the contralateral ear of the rat 
from a mini earphone through the hollow ear bar of the stereotaxic frame. 
 In Experiment I-II, only SS EPs were recorded, using double stimulation. In that, 
the first stimulus was followed by the second one after 300, 240, 180, 120 and 60 ms 
interstimulus intervals (ISIs). A complete record involved 20 “runs”; and in one run 
each ISI occurred once in decreasing order (5 “sweeps”). Recording of 20 “runs” (a 
complete record) took 6 min. Such complete recordings followed in 20 min intervals 
thus the animals had enough time (14 min) for recovery. This stimulation scheme was 
applied, and found sensitive for neurotoxic influences, in earlier experiments of the 
Department. Stimulation, recording of EPs, and analysis of the records (described 
below) was governed by the software Clampex 8.0 (Axon Instruments Inc., USA). 
 The EPs were averaged automatically by the software from the recorded 20 
“runs”, for each double stimulation. On playing them back, cursors were positioned 
manually on the positive and negative peaks of the EPs, generated by the first and 
second stimuli. The cursor positions defined numerical data which were used to 
calculate peak-to-peak amplitude and the latency and amplitude of the positive (first) 
and negative (second) peak of the SS EP. In Experiment I-IV, two recordings per rat 
were made at the end of the treatment period. Data from these two records were 
averaged, then group means were calculated and compared. 
 A novel and important part of the evaluation was the calculation of second:first 
ratio. To do that, each parameter of the second EP was divided by the corresponding 
parameter of the first EP. Second:first ratio calculation was performed in case of each 
animal one by one and from these data, group means were calculated. The second:first 
ratio was interpreted as a measure of dynamic interaction between the two excitation 
processes. 
 In Experiment III and IV, the software NEUROSYS 1.11 (Experimetria Ltd., 
Hungary) was also used for recording cortical activity. In these experiments, 
spontaneous electrical activity (electrocorticogram, ECoG) was first recorded from the 
three cortical areas mentioned above, simultaneously for 6 min. EPs were also recorded 
from each cortical area (SS, VIS, AUD) in Experiment III and IV. Fifty stimuli of each 
modality per rat were applied. 
 From the ECoG records, relative spectral power of the frequency bands and the 
fast/slow activity ratio (“ECoG index”) was determined. EPs were automatically 
averaged off-line, and their parameters (onset latency, duration) were measured 
manually by positioning the cursors of the software to specific points of the EP curve. 
 Previous studies demonstrated that by varying the frequency of stimulation the 
dynamic interaction of successive excitation processes in the sensory system can be 
assessed, which in turn reflects the actual state of the CNS. In theoretical basis and final 
aim, stimulating with varied frequencies was akin to double-pulse stimulation used in 
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the present experiments. Frequency dependence in the parameters of the SS EPs was 
determined by delivering stimuli to the whisker pad also with 2 and 10 Hz frequency, 
beyond the standard 1 Hz. 
 Body weight of the animals was regularly measured during the experiments, to 
follow-up weight gain and to determine the exact daily doses. Following 
electrophysiological recording, the animals were sacrificed by an overdose of urethane, 
were dissected, and blood was collected. Brain, lungs, heart, thymus, liver, kidneys, 
spleen and adrenal glands were removed and the organ weights were measured. From 
these data, relative weights were calculated by relating organ weights to brain weight or 
1/100 of body weight. Metal level was determined from blood, brain and lung samples 
by inductively coupled plasma mass spectrometry at the Laboratory of the MOL 
Hungarian Oil and Gas Company. 
 General toxicological, behavioural and electrophysiological data were tested for 
significance with one-way ANOVA with post-hoc LSD test. Linear regression 
calculations between tissue metal levels and general- and neurotoxicological parameters 
were done by the “linear fit” function of MS Excel. The level of significance was set to 
p<0.05.  
 During the whole study, the principles of the Ethical Committee for the 
Protection of Animals in Research of the University were strictly followed. The 
methods used in the experiments were licensed by the authority competent in animal 
welfare issues under No. XXI./02039/001/2006.  
 
 
 
 Table 1 Treatment schemes of the experiments. 
 
Experiment I 
(Subacute per os) 
Experiment II 
(Subacute intratracheal) 
Experiment III 
(Subacute intratracheal) 
Experiment IV 
(Subacute combined intratracheal) 
Duration 6 weeks 5 weeks 4 weeks 4 weeks 
Groups (with code) and 
number of animals per 
group 
Control: 8 
Treated: 12 
Control (untreated): 6 
Vehicle control: 12 
Treated: 12 
Untreated control (Cont): 6 
Vehicle control for Fe and Mn 
treatment (FMVC): 8 
Low dose Fe3O4 (FeLD): 8 
High dose Fe3O4 (FeHD): 8 
Low dose MnO2 (MnLD): 8 
High dose MnO2 (MnHD): 8 
Vehicle control for Cr treatment 
(CrVC): 8 
Low dose Cr(OH)3 (CrLD): 8 
High dose Cr(OH)3 (CrHD): 8 
Vehicle control (VC): 10 
Fe3O4+ MnO2 (FM): 10 
Fe3O4+ Cr(OH)3 (FC): 10 
MnO2+ Cr(OH)3 (MC): 10 
Fe3O4+ MnO2 +Cr(OH)3 (FMC): 10 
 
Body weight at start 200±20 g 200±20 g 260-280 g 260-280 g 
Substances, doses, 
and way of administration 
MnCl2 
2.5 mg/ml 
po. via drinking water 
MnCl2 
0.5 mg/kg b. w. 
it. 
FeLD: 2 mg/kg b. w. 
FeHD: 4 mg/kg b. w 
MnLD: 2 mg/kg b. w. 
MnHD: 4 mg/kg b. w. 
CrLD: 2 mg/kg b. w. 
CrHD: 4 mg/kg b. w. 
it. 
FM: 2 mg/kg b. w. 
FC: 2 mg/kg b. w. 
MC: 2 mg/kg b. w. 
FMC: 2 mg/kg b. w. 
it. 
Vehicle Tap water Distilled water PAA (FMVC), normal saline (CrVC) Normal saline and PAA 
Investigation 
Electrophysiology 
Dissection 
Organ weighing 
Tissue metal level 
determination 
Electrophysiology 
Dissection 
Organ weighing 
Tissue metal level 
determination 
OF activity 
Electrophysiology 
Dissection 
Organ weighing 
Tissue metal level determination 
OF activity 
Electrophysiology 
Dissection 
Organ weighing  
Tissue metal level determination 
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Results and Conclusion 
 
In Experiment I (subacute po. treatment with MnCl2 solution) neither the body 
weight gain nor the relative organ weights were affected by the treatment. The 
calculated daily Mn intake of the rats in the Treated group was equivalent to 141 mg 
MnCl2, which meant that the cumulative dose of Mn was 1633 mg/rat by the end of the 
6th week. Upon MnCl2 treatment, significant Mn deposition evolved in the treated 
animals’ brain, but not in blood. Second:first ratio of the EPs was shifted to lower 
values in case of the peak-to-peak amplitudes, and of the positive and negative peak 
latencies (the latter two being significant). The absolute latency values had no 
significant change which suggested that the ratio may be a more sensitive indicator. 
In Experiment II (subacute it. treatment with MnCl2 solution) no significant 
effect on the body weight gain in the Treated group was seen, however, relative weight 
(related to 1/100 body weight) of certain organs such as heart and lungs was 
significantly increased. At the end of the treatment, the calculated cumulative dose of 
Mn was merely ca. 1 mg/rat; all the same, Mn concentration in both brain and lungs – 
but not in blood – was significantly elevated. The (non-physiological) absorption of Mn 
from the airways (Experiment II and III) was apparently much more efficient in causing 
toxic internal doses than absorption from the gastrointestinal tract (Experiment I). The 
second:first ratio of the peak-to-peak amplitude showed significant decrease in the 
Treated group (at 240 and 180 ms ISI) which change was basically similar to the 
alteration observed in po. treatment (Experiment I). As to the positive and negative 
peaks, the second:first ratio was lower at all ISIs (significantly at 300 and 240, and 240 
ms respectively). Significant correlation of brain Mn level with the second:first ratio of 
the negative peak amplitude was found at 240 ms ISI.  
 In Experiment III and IV (subacute it. treatment with Mn, Cr or Fe NPs and 
with their combinations) body weight gain of the animals treated with Mn and Cr NPs 
(or their combination) was significantly reduced, and so was the weight gain in case of 
Fe+Cr combination (FC), however, Fe-only treatment lessened the negative effect of the 
treatment procedure. As for the organ weights, the most prominent alteration was the 
increase of the lungs’ relative weight (related to both calculation bases) upon treatment 
with Mn and Cr NPs, and each of the metal NP combinations. In the OF test, local 
activity and immobility was increased and vertical activity was decreased by Cr and Mn 
and by Cr-containing combinations. The effect of Fe NP treatment was opposite. All 
three metal studied tend to be involved in redox cycling, leading to oxidative damage of 
the dopaminergic neurons crucial in motor control; and the observed decreased motility 
could be comparable to symptoms of welders suffering from manganism. In the ECoG, 
application of metal NPs caused a shift to higher frequencies, and this effect of Mn and 
Cr on the SS ECoG was significant, but the alterations caused by the metal NP 
combinations were more pronounced. The observed alterations on the VIS and AUD 
ECoG were similar to those of the SS ECoG. The SS EPs showed significantly 
increased latency on the action of Mn and Cr NPs (and their combination, MC), and of 
FC. In Fe NP treated groups, however, latency was decreased significantly. VIS and 
AUD latency were increased by both doses of Mn, high dose of Cr, and the 
combinations of MC and FC. In case of SS EPs elicited by double pulse stimulation, 
peak-to-peak amplitudes were increased significantly by Mn at almost each ISI. The 
effect of Cr treatment was opposite to Mn, and Fe NP treatment had no noteworthy 
effect alone. The second:first ratio of the peak-to-peak amplitudes was significantly 
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decreased by Mn-only treatment, and the opposite effect of Cr was also seen here. The 
interaction of the two excitation processes, characterized by this ratio, may indicate 
changes in the neurons’ energy supply and in transmitter release and removal In 
combination, the effect of FC and FMC on the second:first ratio was similar to that of 
Cr, whereas no noteworthy change was found in the peak-to-peak amplitudes. Mn and 
Cr content of the brain, lungs, and also blood was significantly increased by Mn and Cr 
NPs respectively, but the effect of Fe was only seen on increased lung Fe levels. In 
combinations, brain and blood levels of Mn were similar to that of caused by Mn alone 
in low dose. Cr levels were, however, influenced by the other metals applied, possibly 
due to interference on Tf and/or other binding sites. The correlation between brain Mn 
levels and SS and VIS ECoG index and SS and VIS latency was significant in Mn-only 
treated groups and also in combination with Cr in MC group. Brain Mn levels also 
correlated with the second:first ratio of the peak-to-peak amplitude. 
 Based on the results described and evaluated above, it can be stated that the 
attempt to model welding fume exposure in rats was successful. In a world where the 
large-scale use of various metals is daily reality and results in occupational exposure 
and environmental pollution the health effects in general, and in particular the effects on 
sensitive systems like the nervous system, are of primary concern. Nanotechnological 
application of metals is another new source of exposure to metal-containing particles, a 
new feature to the old problem. Especially in neurotoxicity, the study of functional 
alterations is important because classical biomarkers – such as levels of toxic metals in 
available human biological samples (blood or urine) – do not indicate well the damage 
to central or peripheral nervous system. This problem has been repeatedly raised in the 
literature. Animal model experiments can contribute to the development of neuro-
functional biomarkers which may be better suited for this purpose. 
 
The questions formulated in the particular point of aims can now be answered as 
follows: 
 The general and nervous system effects of Mn were approximately identical to 
those found in previous experiments. The effects of Cr were, under identical 
conditions, partly similar to those of Mn. This similarity could be due to 
shared mechanisms of action. Data on neurotoxic effects of Cr are scarce in 
the literature so the findings described in this thesis may be novel. The 
effects of Fe were partly minimal, partly opposite to those of Mn. 
 The interactions of the three metal studied were dissimilar on various parameters. 
The effect of Mn on body weight gain, and on electrophysiological and some 
OF parameters, were counteracted by Fe, but Cr was apparently not involved 
in such interaction. In the tissue metal levels, Fe acted on Cr but not on Mn. 
All that indicated that measured internal dose is not the sole determinant of 
the functional alterations and so, not an ideal biomarker of effect. 
 Even when Mn was applied alone, the physicochemical form and site of 
application greatly influenced the resulting internal dose which may be of 
importance in case of various forms of human exposure. 
 Electrophysiological tests, including double pulse stimulation and second:first 
ratio calculation, may well be suitable for detection and follow-up of 
functional damages in the nervous system but the particular form applied in 
the present work turned out not to be optimal. 
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